|
|
||||||||
J Thorac Cardiovasc Surg 2003;125:419-420
© 2003 The American Association for Thoracic Surgery
Brief Communications |
From the Department of Cardiovascular Surgery, Heart Institute of Japan, Tokyo Women's Medical University, Tokyo, Japan.
Received for publication Feb 22, 2002. Accepted for publication July 23, 2002. Address for reprints: Yuji Naito, MD, Department of Cardiovascular Surgery, Heart Institute of Japan, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjyuku-ku, Tokyo, 162-8666, Japan (E-mail: ujinaito@aol.com).
| The first 20% of the full text of this article appears below. |
Currently satisfactory clinical results are observed with the extracardiac Fontan operation (ECFO); however, some issues associated with graft materials must be addressed, such as infection, thrombogenicity, and the lack of growth potential.
1 We report here the case of a patient with occlusion of a graft implanted at initial operation and successfully underwent reoperative ECFO with a tissue-engineered graft.
Clinical summary
A 12-year-old boy had the diagnoses of polysplenia, complete atrioventricular septal defect, small left ventricle, common atrium, bilateral superior vena cava, and hemiazygous connection. A modified Blalock-Taussig shunt and ECFO with a Hemashield graft (Boston Scientific Corporation, Meadox Division, Boston, Mass) were performed at the ages of 9 and 11 years, respectively. The patient had general fatigue 7 months after ECFO. Catheterization demonstrated occlusion of the extracardiac graft. The clinical application of tissue engineering in this patient was approved by the ethical committee at Tokyo Women's Medical University, and the patient's parents were thoroughly informed and consented to the procedure. Graft replacement with a tissue-engineered
This article has been cited by other articles:
![]() |
N. Hibino, T. Yi, D. R. Duncan, A. Rathore, E. Dean, Y. Naito, A. Dardik, T. Kyriakides, J. Madri, J. S. Pober, et al. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts FASEB J, December 1, 2011; 25(12): 4253 - 4263. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Nelson, T. Mirensky, M. P. Brennan, J. D. Roh, T. Yi, Y. Wang, and C. K. Breuer Functional Small-Diameter Human Tissue-Engineered Arterial Grafts in an Immunodeficient Mouse Model: Preliminary Findings Arch Surg, May 1, 2008; 143(5): 488 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lee, C.-H. Lee, S. W. Hwang, H. G. Lim, S.-J. Kim, J. Y. Lee, W.-S. Shim, and W.-H. Kim Midterm follow-up of the status of Gore-Tex graft after extracardiac conduit Fontan procedure Eur J Cardiothorac Surg, June 1, 2007; 31(6): 1008 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ikada Challenges in tissue engineering J R Soc Interface, October 22, 2006; 3(10): 589 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ishii, M. Shin, T. Sueda, and J. P. Vacanti In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix-like topography J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1358 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Isomatsu, T. Shin'oka, G. Matsumura, N. Hibino, T. Konuma, M. Nagatsu, and H. Kurosawa Extracardiac total cavopulmonary connection using a tissue-engineered graft J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1958 - 1962. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |